Phreesia Inc (PHR)
22.61
-0.07
(-0.31%)
USD |
NYSE |
May 07, 16:00
22.61
0.00 (0.00%)
After-Hours: 18:45
Phreesia Revenue (Quarterly): 95.00M for Jan. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 95.00M |
October 31, 2023 | 91.62M |
July 31, 2023 | 85.83M |
April 30, 2023 | 83.84M |
January 31, 2023 | 76.59M |
October 31, 2022 | 73.10M |
July 31, 2022 | 67.87M |
April 30, 2022 | 63.35M |
January 31, 2022 | 58.02M |
October 31, 2021 | 55.92M |
July 31, 2021 | 51.01M |
April 30, 2021 | 48.29M |
Date | Value |
---|---|
January 31, 2021 | 41.81M |
October 31, 2020 | 38.46M |
July 31, 2020 | 35.01M |
April 30, 2020 | 33.40M |
January 31, 2020 | 32.82M |
October 31, 2019 | 32.84M |
July 31, 2019 | 30.82M |
April 30, 2019 | 28.31M |
January 31, 2019 | 26.48M |
October 31, 2018 | 24.76M |
July 31, 2018 | 24.78M |
April 30, 2018 | 23.87M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
30.82M
Minimum
Jul 2019
95.00M
Maximum
Jan 2024
57.66M
Average
55.92M
Median
Oct 2021
Revenue (Quarterly) Benchmarks
Teladoc Health Inc | 646.13M |
American Shared Hospital Services | 5.698M |
Novo Integrated Sciences Inc | 3.171M |
Astrana Health Inc | 353.04M |
Cryo-Cell International Inc | 7.852M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -30.65M |
Total Expenses (Quarterly) | 124.58M |
EPS Diluted (Quarterly) | -0.55 |
Enterprise Value | 1.194B |
Gross Profit Margin (Quarterly) | 66.56% |
Profit Margin (Quarterly) | -32.26% |
Earnings Yield | -11.10% |
Normalized Earnings Yield | -11.10 |